Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome
- PMID: 21354109
- DOI: 10.1016/j.brainres.2011.02.060
Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive degenerative disorder affecting motoneurons and the SOD1(G93A) transgenic mice are widely employed to study disease physiopathology and therapeutic strategies. Despite the cellular and biochemical evidences of an early motor system dysfunction, the conventional behavioral tests do not detect early motor impairments in SOD1 mouse model. We evaluated early changes in motor behavior of ALS mice by doing the analyses of tail elevation, footprint, automatic recording of motor activities by means of an infrared motion sensor activity system and electrophysiological measurements in male and female wild-type (WT) and SOD1(G93A) mice from postnatal day (P) 20 up to endpoint. The classical evaluations of mortality, weight loss, tremor, rotometer, hanging wire and inclined plane were also employed. There was a late onset (after P90) of the impairments of classical parameters and the outcome varied between genders of ALS mice, being tremor, cumulative survival, weight loss and neurological score about 10 days earlier in male than female ALS mice and also about 20 days earlier in ALS males regarding rotarod and hanging wire performances. While diminution of hindpaw base was 10 days earlier in ALS males (P110) compared to females, the steep length decreased 40 days earlier in ALS females (P60) than ALS males. The automatic analysis of motor impairments showed substantial late changes (after P90) of motility and locomotion in the ALS females, but not in the ALS males. It was surprising that the scores of tail elevation were already decreased in ALS males and females by P40, reaching the minimal values at the endpoint. The electrophysiological analyses showed early changes of measures in the ALS mouse sciatic nerve, i.e., decreased values of amplitude (P40) and nerve conduction velocity (P20), and also an increased latency (P20) reaching maximal level of impairments at the late disease phase. The early changes were not accompanied by reductions of neuronal protein markers of neurofilament 200 and ChAT in the ventral part of the lumbar spinal cord of P20 and P60 ALS mice by means of Western blot technique, despite remarkable decreases of those protein levels in P120 ALS mice. In conclusion, early changes of motor behavior and electrophysiological parameters in ALS mouse model must be taken into attention in the analyses of disease mechanisms and therapeutic effects.
Copyright © 2011. Published by Elsevier B.V.
Similar articles
-
Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.Neuroscience. 2015 Jul 9;298:12-25. doi: 10.1016/j.neuroscience.2015.03.061. Epub 2015 Apr 1. Neuroscience. 2015. PMID: 25841320
-
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.Neurobiol Dis. 2014 Apr;64:48-59. doi: 10.1016/j.nbd.2013.11.006. Epub 2013 Dec 19. Neurobiol Dis. 2014. PMID: 24361555
-
GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.Neurobiol Dis. 2015 Jun;78:12-23. doi: 10.1016/j.nbd.2015.03.010. Epub 2015 Mar 25. Neurobiol Dis. 2015. PMID: 25818008
-
Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis.J Physiol Paris. 2006 Mar-May;99(2-3):211-20. doi: 10.1016/j.jphysparis.2005.12.014. Epub 2006 Jan 30. J Physiol Paris. 2006. PMID: 16448809 Review.
-
State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model.Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):1-14. doi: 10.3109/21678421.2015.1047455. Epub 2015 May 22. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 25998063 Free PMC article. Review.
Cited by
-
Hypolipidemia in patients with amyotrophic lateral sclerosis: a possible gender difference?J Clin Neurol. 2013 Apr;9(2):125-9. doi: 10.3988/jcn.2013.9.2.125. Epub 2013 Apr 4. J Clin Neurol. 2013. PMID: 23626651 Free PMC article.
-
Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS.Commun Biol. 2021 Apr 30;4(1):509. doi: 10.1038/s42003-021-02034-z. Commun Biol. 2021. PMID: 33931719 Free PMC article.
-
Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis.Front Cell Neurosci. 2015 Sep 1;9:332. doi: 10.3389/fncel.2015.00332. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26339226 Free PMC article.
-
Gene Therapy Overexpressing Neuregulin 1 Type I in Combination With Neuregulin 1 Type III Promotes Functional Improvement in the SOD1G93A ALS Mice.Front Neurol. 2021 Sep 22;12:693309. doi: 10.3389/fneur.2021.693309. eCollection 2021. Front Neurol. 2021. PMID: 34630277 Free PMC article.
-
Early gene expression changes in spinal cord from SOD1(G93A) Amyotrophic Lateral Sclerosis animal model.Front Cell Neurosci. 2013 Nov 18;7:216. doi: 10.3389/fncel.2013.00216. eCollection 2013. Front Cell Neurosci. 2013. PMID: 24302897 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous